Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates.

Endocrinology | 2013

Previous studies in rodents and humans suggest that hyperandrogenemia causes white adipose tissue (WAT) dysfunction in females, although the underlying mechanisms are poorly understood. In light of the differences in the length of the ovarian cycle between humans and rodents, we used a nonhuman primate model to elucidate the effects of chronic hyperandrogenemia on WAT function in vivo. Female rhesus macaques implanted with testosterone capsules developed insulin resistance and altered leptin secretion on a high-fat, Western-style diet. In control visceral WAT, lipolysis and hormone-sensitive lipase expression were upregulated during the luteal phase compared with the early follicular (menses) phase of the ovarian cycle. Hyperandrogenemia attenuated elevated lipolysis and hormone-sensitive lipase activity in visceral WAT during the luteal phase but not during menses. Under control conditions, insulin-stimulated Akt and Erk activation and fatty acid uptake in WAT were not significantly affected by the ovarian cycle. In contrast, testosterone treatment preferentially increased fatty acid uptake and insulin signaling at menses. The fatty acid synthase and glucose transporter-4 genes were upregulated by testosterone during the luteal phase. In summary, this study reveals ovarian stage-specific fluctuations in adipocyte lipolysis and suggests that male sex hormones increase and female sex hormones decrease lipid storage in female WAT.

Pubmed ID: 24008344 RIS Download

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: U54HD071836
  • Agency: NIDDK NIH HHS, United States
    Id: K08 DK074397
  • Agency: NCRR NIH HHS, United States
    Id: R21 RR030276
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD071836
  • Agency: NIDDK NIH HHS, United States
    Id: R03DK095050
  • Agency: NIDDK NIH HHS, United States
    Id: R01DK097449
  • Agency: NIDDK NIH HHS, United States
    Id: R03 DK095050
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK097449
  • Agency: NCRR NIH HHS, United States
    Id: R21RR030276
  • Agency: NIDDK NIH HHS, United States
    Id: K08DK074397
  • Agency: NICHD NIH HHS, United States
    Id: P50 HD071836

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.